previous year. The net loss was Baht 13.64 million, representing an increase of Baht 17.16 million. Up to 125.81 percent. The causes are as follows. 1. Sales and service income increased from Baht 133.41
and Q2/2018 respectively, An increase in total revenue 20.4% and can be summarized as following. Q-O-Q Change Q2/2017 Q2/2018 Increase/(Decrease) Sales 196.4 240.8 22.6% The sales volume increases as
that, operating expenses rose by Baht 5.42 million because of the increase of the amount of employee benefit obligations in according with the accounting standard. The ratio of net claim expense over
property of the company. 4. Allowance for doubtful accounts 11.37 with last year at 1.26 million baht which increase 10.11 million baht or 800.46% Due to reversal of allowance for doubtful accounts from
225.26 Million to see a Gross Profit of 18.54% while in the same period of last year to Baht 211.64 Million and 12.69 % respectively. The significant increase of gross profit in the second quarter of 2018
. 2. Selling and Administrative Expenses Selling and Administrative Expenses increase in accordance with sales. In Q2/2018, the company’s selling and administrative expenses were 124.45 million baht
2017. Net Profit (Loss) for Q3 year 2018 and Q3 year 2017 was 36.54 million baht and 36.54 million baht. It increased 1.22 million baht or 2.41 % from Q3 year 2017. The reason was increase in sales and
the same period of 2018 which has a net profit of 3.19 million baht, an increase of 16.92 million baht or an increase of 529.78 percent by significant changes are as follows - The company has sales
377.85 million, comparing at the same period in 2018 representing 70.30% increase. This is mainly due to : 1. Income from medical treatments in the consolidated financial went up 3.38% due to income from
, Indonesia and India markets experienced in 2019. For Malaysia market, although the TIV shown slightly improved from 2018, but it does not translate into a higher sales revenue mainly the increase was